CS logo
small CS logo
Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie

Dresden, Germany
Hospital department in Dresden, Saxony
Fetscherstraße 74, 01307 Dresden

About Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


During the past decade, Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


According to Clinical.Site data, the most researched conditions in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie" are "Prostate Cancer" (2 trials), "Renal Cell Carcinoma" (2 trials), "Bladder Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie" in a lesser frequency.

Clinical Trials Intervention Types at Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


Most popular intervention types in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


The vast majority of trials in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie" are 5 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie


Currently, there are NaN active trials in "Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum "Carl Gustav Carus"; Klinik und Poliklinik für Urologie, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".